Literature DB >> 34747415

A comparative study on the secretion of various cytokines by pulp stem cells at different passages and their neurogenic potential.

Ming Yan1,2, Ola A Nada3, Ling-Ling Fu1,2, Dong-Zhen Li4, Hong-Chao Feng2, Li-Ming Chen2, Martin Gosau1, Reinhard E Friedrich1, Ralf Smeets1.   

Abstract

AIMS: By measuring the extent of cytokines secreted by human dental pulp stem cells (hDPSCs) from passages 2 through 10, the optimal passage of hDPSCs was determined. This offers a potential theoretical basis for the treatment of neurological disorders.
METHOD: After isolation and culture of hDPSCs from human teeth, the morphological features of the cells were observed under an inverted microscope. hDPSCs were identified by their immunophenotypes and their multiple differentiation capability. Cytokine concentrations secreted in the supernatants at passages 2-10 were detected by ELISA.
RESULTS: hDPSCs were viewed as fusiform or polygonal in shape, with a bulging cell body, homogenized cytoplasm, and a clear nucleus. Moreover, they could differentiate into neuroblasts in vitro. hDPSCs at passage 3 were positive for CD29 (91.5%), CD73 (94.8%) and CD90 (96.7%), but negative for the hematopoietic markers CD34 (0.13%). ELISA results showed that hDPSCs at passage 3 had the highest secretion levels of vascular endothelial growth factor (VEGF), brain-derived neurotrophic factor (BDNF), and nerve growth factor (NGF), with the highest secretion level of Neurotrophin-3 (NT-3) being at passage 2.
CONCLUSION: hDPSCs have steady biological features of stem cells and exhibit optimal proliferation potential. hDPSCs at different passages have different capacities in the secretion of VEGF, BDNF, NGF, and NT-3. In conclusion cytokines secreted by hDPSCs may prove to be appropriate in the treatment of neurological diseases.

Entities:  

Keywords:  brain-derived neurotrophic factor; cytokines; dental pulp stem cell; multidirectional differentiation; nerve growth factor; neurotrophin-3. immunophenotype; vascular endothelial growth factor

Mesh:

Substances:

Year:  2021        PMID: 34747415     DOI: 10.5507/bp.2021.058

Source DB:  PubMed          Journal:  Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub        ISSN: 1213-8118            Impact factor:   1.245


  15 in total

1.  Multipotent mesenchymal stem cells with immunosuppressive activity can be easily isolated from dental pulp.

Authors:  Laura Pierdomenico; Laura Bonsi; Mario Calvitti; Damiano Rondelli; Mario Arpinati; Gabriella Chirumbolo; Ennio Becchetti; Cosetta Marchionni; Francesco Alviano; Valentina Fossati; Nicola Staffolani; Michele Franchina; Alberto Grossi; Gian Paolo Bagnara
Journal:  Transplantation       Date:  2005-09-27       Impact factor: 4.939

2.  Expression pattern of Oct-4, Sox2, and c-Myc in the primary culture of human dental pulp derived cells.

Authors:  Lu Liu; Xi Wei; Junqi Ling; Liping Wu; Yin Xiao
Journal:  J Endod       Date:  2011-02-25       Impact factor: 4.171

Review 3.  Neural crest-derived dental stem cells--where we are and where we are going.

Authors:  Vera Mayo; Yoh Sawatari; C-Y Charles Huang; Franklin Garcia-Godoy
Journal:  J Dent       Date:  2014-04-24       Impact factor: 4.379

4.  Mesenchymal stem cells from human dental pulp: isolation, characteristics, and potencies of targeted differentiation.

Authors:  R A Poltavtseva; Yu A Nikonova; I I Selezneva; A K Yaroslavtseva; V N Stepanenko; R S Esipov; S V Pavlovich; I V Klimantsev; N V Tyutyunnik; T K Grebennik; A V Nikolaeva; G T Sukhikh
Journal:  Bull Exp Biol Med       Date:  2014-11-19       Impact factor: 0.804

Review 5.  Stem cell therapy. Use of differentiated pluripotent stem cells as replacement therapy for treating disease.

Authors:  Ira J Fox; George Q Daley; Steven A Goldman; Johnny Huard; Timothy J Kamp; Massimo Trucco
Journal:  Science       Date:  2014-08-22       Impact factor: 47.728

6.  Intravitreally transplanted dental pulp stem cells promote neuroprotection and axon regeneration of retinal ganglion cells after optic nerve injury.

Authors:  Ben Mead; Ann Logan; Martin Berry; Wendy Leadbeater; Ben A Scheven
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-11-15       Impact factor: 4.799

Review 7.  The therapeutic potential of cell identity reprogramming for the treatment of aging-related neurodegenerative disorders.

Authors:  Derek K Smith; Miao He; Chun-Li Zhang; Jialin C Zheng
Journal:  Prog Neurobiol       Date:  2016-02-01       Impact factor: 11.685

Review 8.  Stem cells for the treatment of neurodegenerative diseases.

Authors:  Elise Dantuma; Stephanie Merchant; Kiminobu Sugaya
Journal:  Stem Cell Res Ther       Date:  2010-12-10       Impact factor: 6.832

9.  Paracrine-mediated neuroprotection and neuritogenesis of axotomised retinal ganglion cells by human dental pulp stem cells: comparison with human bone marrow and adipose-derived mesenchymal stem cells.

Authors:  Ben Mead; Ann Logan; Martin Berry; Wendy Leadbeater; Ben A Scheven
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

Review 10.  The potential of mesenchymal stem cells derived from amniotic membrane and amniotic fluid for neuronal regenerative therapy.

Authors:  Eun Young Kim; Kyung-Bon Lee; Min Kyu Kim
Journal:  BMB Rep       Date:  2014-03       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.